Xianghong Jasmine Zhou
Vorstandsvorsitzender bei EarlyDiagnostics, Inc.
Profil
Xianghong Jasmine Zhou is the founder of EarlyDiagnostics, Inc., a company she founded in 2017.
She currently holds the titles of President, Co-CEO, and Chief Financial Officer at EarlyDiagnostics, Inc.
Aktive Positionen von Xianghong Jasmine Zhou
| Unternehmen | Position | Beginn |
|---|---|---|
EarlyDiagnostics, Inc.
 EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | Vorstandsvorsitzender | 01.01.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | Technology Services |
